SAKAR

What Sakar Healthcare promised, and what happened

Every commitment management made on a call, tracked from the quarter it was made — reaffirmed, revised, diluted or quietly dropped.

Guidance record · Q1 FY27

what the last two calls moved 23 tracked 2 delivered 2 missed 19 open
  • EBITDA Margin delivered said Q2 FY26 Promised: 25% for FY26 Q1 FY27: This is a closed promise from a prior fiscal year. The final verdict remains 'achieved'.
  • Revenue missed said Q2 FY26 Promised: ₹280 crores for FY26 Q1 FY27: This is a closed promise from a prior fiscal year. The final verdict remains 'missed'.
  • Oncology EBITDA Margin revised up said Q3 FY26 Promised: 30% EBITDA margin Q1 FY27: Management guided that margins will be 'soon crossing the 30% margin EBITDA' by the end of FY27, strengthening the previously diluted guidance.

The rest of the ledger

Above is what the last two calls moved. Pro opens all 23 tracked commitments for Sakar Healthcare — every quarter's revision, the source quote behind each one, and the topics management has stopped answering.

See what Pro opens